SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is trending due to recent Saudi FDA approval for its Anktiva treatment in both lung and bladder cancer, marking a significant global expansion, alongside positive clinical updates for its CAR-NK program. This flurry of news has sparked immense trading volume and strong bullish sentiment, with the community eagerly discussing the potential for a short squeeze and the long-term impact of its innovative cancer therapies.

Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. It operates under the United States and International geographical segments. The company was founded on November 22, 2002 and is headquartered in Toronto, Canada.

Venus Concept Inc

Venus Concept (VERO) is trending following news that a major investor acquired a 91% stake, sparking widespread speculation about a potential delisting or privatization to reduce operational costs. This significant ownership concentration has ignited intense community debate, with many discussing the potential for a monumental short squeeze, while others caution about risks like dilution or market correction as traders weigh holding over the long weekend.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network ($ZBCN) is trending as the community eagerly anticipates its Super App launch and discusses recent integrations, including a notable partnership with World Liberty Finance for on-chain payroll and card services. Investors are highlighting its robust ISO 20022 and MiCA compliance, positioning it as an undervalued utility project with significant long-term growth potential in real-world payments.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is currently a focal point for investors, primarily due to intense market speculation about artificial intelligence potentially disrupting its established software ecosystem, a sentiment further amplified by recent analyst downgrades. This has sparked a sharp debate among the community; while many express significant concern over the company's long-term viability in an AI-driven landscape, others are seizing the opportunity, emphasizing Adobe's strong cash flow and market position as fundamentally undervalued.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

The community is buzzing around Applovin's recent sharp decline, with many attributing it to "max pain" options manipulation and broader software sector weakness, despite multiple analyst upgrades and strong growth prospects for its AI-powered Axon Ads platform. This divergence is fueling active debate among traders, with some seeing a prime dip-buying opportunity while others warn of perceived overvaluation and potential regulatory risks. Traders are closely watching for a rebound, especially with upcoming earnings reports on the horizon.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is trending due to significant share price declines, hitting multi-year lows amidst widespread investor frustration and calls for CEO Jeff Green's accountability. Community discussion centers on whether the steep sell-off is capitulation or signals deeper issues like increasing competition and broader ad-tech sector struggles. Many are questioning the company's future, while some see a long-term buying opportunity in its oversold state, with upcoming earnings being a key focus for investors.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma ($FIG) is a major trending topic as its stock continues a steep decline, prompting widespread community frustration over perceived insider selling and impending lockup expiries. Many investors are questioning the company's long-term viability amid concerns about AI replacing design roles and its valuation compared to competitors like Adobe. However, a segment of the community views the sharp pullback as a unique buying opportunity, betting on Figma's strong product and market leadership in collaborative design.

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

Riot Platforms is trending due to its pivotal shift toward AI and high-performance computing, highlighted by a new multi-year data center lease with AMD at its Rockdale facility and the acquisition of the underlying land. The community views this as a transformative strategic move, validating the company's potential as a major AI infrastructure provider and distinguishing it favorably against some peers in the sector.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Holdings Inc

Ondas Holdings (ONDS) is attracting speculative interest, with community members identifying it among a group of 'next generation' stocks anticipated for substantial gains. This excitement is driving active discussions where bullish investors are vigorously countering any bearish sentiment regarding the stock's potential trajectory.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is surging following its selection as a prime contract awardee for the U.S. Missile Defense Agency's SHIELD program, which is seen by the community as a significant validation for its unique direct-to-cell technology. Long-term holders are celebrating this 'Golden Dome' involvement, viewing it as a clear path to future revenue streams and a blow to short sellers, while eagerly awaiting further commercial and deployment news.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Anixa Biosciences (NASDAQ:ANIX) Issues Earnings Results, Meets Expectations

Anixa Biosciences (NASDAQ:ANIX - Get Free Report) posted its earnings results on Monday. The company reported ($0.09) earnings per share (EPS) for the quarter, hitting the consensus estimate of...

Anixa Biosciences Inc (NASDAQ:ANIX) Given Average Recommendation of "Hold" by Brokerages

Shares of Anixa Biosciences Inc (NASDAQ:ANIX - Get Free Report) have been assigned an average rating of "Hold" from the five brokerages that are currently covering the stock, MarketBeat Ratings...

Anixa Biosciences (ANIX) Expected to Announce Quarterly Earnings on Friday

Anixa Biosciences (NASDAQ:ANIX) will be releasing its Q4 2025 earnings before the market opens on Friday, January 9. (View Earnings Report at...

Anixa Biosciences Inc (NASDAQ:ANIX) Sees Significant Increase in Short Interest

Anixa Biosciences Inc (NASDAQ:ANIX - Get Free Report) saw a large increase in short interest in December. As of December 15th, there was short interest totaling 795,400 shares, an increase of 40.7...

Anixa Biosciences (NASDAQ:ANIX) Stock Rating Lowered by Wall Street Zen

Wall Street Zen downgraded shares of Anixa Biosciences from a "hold" rating to a "sell" rating in a report on Saturday...

Anixa Biosciences (NASDAQ:ANIX) Given "Buy" Rating at D. Boral Capital

D. Boral Capital reaffirmed a "buy" rating and issued a $10.00 price target on shares of Anixa Biosciences in a research note on Friday...

Anixa Biosciences Shares Jump Over 15% In After-Hours Trading Here's Why

Anixa Biosciences shares surged in after-hours trading after presenting clinical trial data for its investigational breast cancer vaccine.read more...

Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants

Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants Anixa Biosciences Announces...

Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025

Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025 Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025...

Anixa Biosciences (NASDAQ:ANIX) Stock Rating Lowered by Zacks Research

Zacks Research downgraded Anixa Biosciences from a "strong-buy" rating to a "hold" rating in a research note on Tuesday...

Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology. It operates through the following segments: Cancer Vaccines, CAR-T Therapeutics, and Other. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The CAR-T Therapeutics segment is involved in the development of immuno-therapy drugs against cancer. The Other segment refers to its legacy operations, including patent licensing. The company was founded on November 5, 1982 and is headquartered San Jose, CA.

Current Price	$3.19
Prev Close	$3.22
Open	$3.22
Dividend Yield	0.00%
50-Day Moving Average	$3.92
Beta	1.16
Avg. Volume	510,688.32
PE Ratio	-9.56

52-Week High	$5.46
52-Week Low	$2.33
Market Capitalization	$107.47M
EPS (Annual)	-$0.3367
Price to Book	7.01
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

ANIX
Anixa Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ANIX News

ANIXAnixa Biosciences Inc